Jpmorgan Chase & CO Orgenesis Inc. Put Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ORGS
# of Institutions
16Shares Held
1.54MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA910KShares$1.09 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA283KShares$339,6920.0% of portfolio
-
Black Rock Inc. New York, NY79.9KShares$95,8660.0% of portfolio
-
State Street Corp Boston, MA78.9KShares$94,6530.0% of portfolio
-
Ronit Capital LLP54.2KShares$65,0000.1% of portfolio
About Orgenesis Inc.
- Ticker ORGS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,545,800
- Market Cap $30.7M
- Description
- Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...